Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice.
B类清道夫受体I型和II型以及CD36靶向治疗可改善小鼠脓毒症的存活率和急性预后
期刊:Journal of Immunology
影响因子:3.4
doi:10.4049/jimmunol.1003445
Leelahavanichkul Asada, Bocharov Alexander V, Kurlander Roger, Baranova Irina N, Vishnyakova Tatyana G, Souza Ana C P, Hu Xuzhen, Doi Kent, Vaisman Boris, Amar Marcelo, Sviridov Denis, Chen Zhigang, Remaley Alan T, Csako Gyorgy, Patterson Amy P, Yuen Peter S T, Star Robert A, Eggerman Thomas L
